Skip to main content
Log in

New cell lines with chondrocytic phenotypes from human chondrosarcoma

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

In the present study, we investigated chondrocytic characterization for newly established human chondrosarcoma cell lines. A chondrosarcoma cell line, HCS-TG, was established by the implantation of grade-2 human chondrosarcoma into athymic mice. Cloning of HCS-TG cells from passage 17 was performed. After cell cloning, two clonal-cell lines (HCS-TG C3 and E2) with good proliferative activities were obtained. These cell lines in monolayer culture retained a polygonal morphology. Their doubling times were 68 h and 45 h, respectively. mRNA expressions of type-I, -II, -X, and -XI collagens and aggrecan core protein were detected on reverse-transcription polymerase chain reaction. Protein expression of type-II collagen was confirmed in each cell line using Western blotting. However, there was no expression of type-I collagen. Moreover, gelatin zymography revealed that both cell lines produced extracellular matrices with matrix metalloproteinases 2 and 9. The parental HCS-TG cells had tumorigenicity in athymic mice; however, C3 and E2 were not tumorigenic. New clonal-cell lines HCS-TG C3 and E2 derived from human chondrosarcoma are morphologically chondrocytic in serial monolayer cultures and express chondrocytic phenotypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Aigner T, Dertinger S, Vornehm SI, Dudhia J, von der Mark K, Kirchner T (1997) Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasm. Am J Pathol 150:2133–2141

    CAS  PubMed  Google Scholar 

  2. Aigner T, Müller S, Neureiter D, lllstrup DM, Kirchner T, Björnson J (2002) Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 94:2273–2281

    Article  PubMed  Google Scholar 

  3. Berend KR, Toth AP, Harrelson JM, Layfield LJ, Hey LA, Scully SP (1998) Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am 80:11–17

    Article  CAS  PubMed  Google Scholar 

  4. Block JA, Inerot S, Gitelis S, Kimura JH (1991) Synthesis of chondrocytic keratan sulphate-containing proteoglycans by human chondrosarcoma cells in long-term cell culture. J Bone Joint Surg Am 73:647–658

    CAS  PubMed  Google Scholar 

  5. Boström H, Friberg U, Larsson KS, Nilsonne U (1968) In vitro incorporation of S35-sulfate in chondrosarcomatous tissue. Acta Orthop Scandinav 39:58–72

    Google Scholar 

  6. Bridge JA, Bhatia PS, Anderson JR, Neff JR (1993) Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet 69:79–90

    Article  CAS  PubMed  Google Scholar 

  7. Burgeson R (1998) New collagens, new concepts. Ann Rev Cell Biol 4:551–577

    Google Scholar 

  8. Burgeson RE, Hollister DW (1979) Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biopys Res Commun 87:1124–1131

    CAS  Google Scholar 

  9. Chandrasekhar S, Esterman M, Hoffman HA (1987) Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem 161:103–108

    CAS  PubMed  Google Scholar 

  10. Chano T, Okabe H, Saeki Y, Ishizawa M, Matsumoto K, Hukuda S (1998) Characterization of a newly established human chondrosarcoma cell line, CS-OKB. Virchows Arch 432:529–534

    Article  CAS  PubMed  Google Scholar 

  11. Chansky H, Robbins JR, Cha S, Raskind WH, Conrad EU, Sandell LJ (1998) Expression of cartilage extracellular matrix and potential regulatory genes in a new human chondrosarcoma cell line. J Ortop Res 16:521–530

    CAS  Google Scholar 

  12. Dijkhuizen T, Berg E, Molenaar WM, Oosterhuis JW, Dam A, Wiersema J, Koops H, de Jong B (1994) Cytogenetics as a tool in the histologic subclassification of chondrosarcoma. Cancer Genet Cytogenet 76:100–105

    Article  CAS  PubMed  Google Scholar 

  13. Elima K, Vuorio E (1989) Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett 258:195–198

    Article  CAS  PubMed  Google Scholar 

  14. Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40:818–831

    CAS  PubMed  Google Scholar 

  15. Fletcher JA, Lipinski KK, Weidner N, Morton CC (1989) Complex cytogenetic aberrations in a well-differentiated chondrosarcoma. Cancer Genet Cytogenet 41:115–121

    Article  CAS  PubMed  Google Scholar 

  16. Gil-Benso R, Lopez-Gines C, López-Guerrero JA, Carda C, Callaghan RC, Navarro S, Ferrer J, Pellín A, Llombart-Bosch A (2003) Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin. Lab Invest 83:877–887

    CAS  PubMed  Google Scholar 

  17. Gowen M, Wood DD, Ihrie EJ, Meats JE, Russell RGG (1984) Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. Biochim Biophys Acta 797:186–193

    Article  CAS  PubMed  Google Scholar 

  18. Herwig J, Roessner A, Buddecke E (1986) Isolation and characterization of proteoglycans and glycosaminoglycans from human chondrosarcoma. Exp Mol Pathol 45:118–127

    Article  CAS  PubMed  Google Scholar 

  19. Hirabayashi Y, Yoshida MA, Ikeuchi T, Ishida T, Kojima T, Higaki S, Machinami R, Tonomura A (1992) Chromosomal rearrangements at 12q13 in two cases of chondrosarcomas. Cancer Genet Cytogenet 60:35–40

    Article  CAS  PubMed  Google Scholar 

  20. Huvos AG (1991) Chondrosarcoma including spindle-cell (dedifferentiated) and myxoid chondrosarcoma; mesenchymal chondrosarcoma. In: Huvos AG (ed) Bone tumors. W.B. Saunders Company, Philadelphia, pp 343–381

  21. Kaplan D, Meyer K (1959) Ageing of human cartilage. Nature (London) 183:1267–1268

  22. Kawashima A, Ueda Y, Tsuchiya H, Tomita K, Nagai Y, Nakanishi I (1993) Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen. J Cancer Res Clin Oncol 120:35–40

    CAS  PubMed  Google Scholar 

  23. Kawashima A, Okada Y, Nakanishi I, Ueda Y, Iwata K, Roessner A (1997) Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Gen Diagn Pathol 142:129–137

    CAS  PubMed  Google Scholar 

  24. Kunisada T, Miyazaki M, Mihara K, Gao C, Kawai A, Inoue H, Namba M (1998) A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 77:854–859

    Article  CAS  PubMed  Google Scholar 

  25. Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg, AE, Jennigs, LC (1999) Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81:326–337

    Google Scholar 

  26. Mandahl N, Heim S, Arheden K, Rydholm A, Willén H, Mitelman F (1990) Chromosomal rearrangements in chondromatous tumors. Cancer 65:242–248

    CAS  PubMed  Google Scholar 

  27. Mankin HJ, Cantley KP, Lippiello L, Schiller AL, Campbell CJ (1980) The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses. J Bone Joint Surg Am 62:160–175

    CAS  PubMed  Google Scholar 

  28. Mankin HJ, Cantley KP, Schiller AL, Lippiello L (1980) The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors. J Bone Joint Surg Am 62:176–188

    CAS  PubMed  Google Scholar 

  29. Mathews MB, Glacov S (1966) Acid mucopolysaccharide patterns in aging human cartilage. J Clin Invest 45:1103–1111

    CAS  PubMed  Google Scholar 

  30. Miller E, Gay S (1987) The collagens: an overview and update. In: Colowick SP and Kaplan NO (eds) Methods in enzymology. 144 Academic Press, Inc., London, pp 3–41

  31. Mirra JM, Eckardt JJ (1989) Enchondroma versus chondrosarcoma. In: Mirra JM (ed) Bone tumors. Lea & Febiger, Philadelphia, pp 476–535

  32. Morris NP, Bächinger HP (1987) Type XI collagen is a heterotrimer with the composition (1 alpha, 2 alpha, 3 alpha) retaining non-triple-helical domains. J Biol Chem 262:11345–11350

    CAS  PubMed  Google Scholar 

  33. Mourão PAS, Rozenfeld S, Laredo J, Dietrich CP (1976) The distribution of chondroitin sulfates in articular and growth cartilage of human bones. Biochem Biophys Acta 428:19–26

    PubMed  Google Scholar 

  34. Mourão PAS, Michelacci YM, Toledo OMS (1979) Glycosaminoglycans and proteoglycans of normal and tumoral cartilages of humans and rats. Cancer Res 39:2802–2806

    PubMed  Google Scholar 

  35. Müller PK, Lemmen C, Gay S, Gauss V, Kühn K (1977) Immunochemical and biochemical study of collagen synthesis by chondrocytes in culture. Exp Cell Res 108:47–55

    PubMed  Google Scholar 

  36. Nakamura Y, Becker LE, Marks A (1983) S-100 protein in tumors of cartilage and bone. 52:1820–1824

  37. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, Bayliss MT, Iwata K, Nagase H (1992) Localization of matrix metalloproteinase3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680–690

    CAS  PubMed  Google Scholar 

  38. Okajima K, Honda I, Kitagawa T (1988) Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage. Cancer 61:792–799

    CAS  PubMed  Google Scholar 

  39. Powell WC, Matrisian LM (1996) Complex roles of matrix metalloproteinases in tumor progression. In: Günthert U, Birchmeier W (eds) Attempts to understand metastasis formation I. Springer Verlag, Berlin Heidelberg New York, pp 1–21

  40. Saito S, Katoh M, Matsumoto M, Matsumoto S, Masuho Y (1997) Collagen degradation induced by the combination of IL-1 alpha and plasminogen in rabbit articular cartilage explant culture. J Biochem 122:49–54

    CAS  PubMed  Google Scholar 

  41. Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M (1999) Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma. J Cancer Res Clin Oncol 125:541–548

    Article  CAS  PubMed  Google Scholar 

  42. Sheth DS, Yasko AW, Johnson ME, Alaya AG, Murray JA, Romsdahl MM (1996) Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery. Cancer 15:745–750

    Article  Google Scholar 

  43. Shinmei M, Masuda K, Kikuchi T, Shimomura Y (1989) The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol 16[Suppl]:32–34

  44. Sweet MBE, Thonar EJAL, Immelman AR (1976) Glycosaminoglycans and proteoglycans of human chondrosarcoma. Biochem Biophys Acta 437:71–86

    Article  CAS  PubMed  Google Scholar 

  45. Takigawa M, Tajima K, Pan HO, Enomoto M, Kinoshita A, Suzuki F, Takano Y, Mori Y (1989) Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res 49:3996–4002

    CAS  PubMed  Google Scholar 

  46. Thonar EJA, Sweet MBE, Immelman AR, Lyons G (1979) Structural studies on proteoglycan from human chondrosarcoma. Arch Biochem Biophys 194:179–189

    CAS  PubMed  Google Scholar 

  47. Ueda Y, Oda Y, Tsuchiya H, Tomita K, Nakanishi I (1990) Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone. Virchows Archiv 417:291–297

    CAS  PubMed  Google Scholar 

  48. Unni KK (1996) Chondrosarcoma. In: Unni KK (ed) Dahlin’s bone tumors. Lippincott-Raven, Philadelphia, pp 71–108

  49. Uría JA, Balbín M, López JM, Alvares J, Vizoso F, Takigawa M, López-Otín C (1998) Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 153:91–101

    CAS  PubMed  Google Scholar 

  50. Weiss APC, Dorfman HD (1986) S-100 protein in human cartilage lesions. J Bone Joint Surg Am 68:521–526

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Noriyuki Tsumaki, M.D. Ph.D., Takanobu Nakase, M.D. Ph.D., and Tetsuya Tomita, M.D. Ph.D., for provision of primers of collagens and to Akihiko Matsumine, M.D. Ph.D., and Yukihiro Isogai, Ph.D., for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ikuo Kudawara.

Additional information

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. This work was partly supported by the grants from the Japanese Ministry of Education, Science and Culture.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kudawara, I., Araki, N., Myoui, A. et al. New cell lines with chondrocytic phenotypes from human chondrosarcoma. Virchows Arch 444, 577–586 (2004). https://doi.org/10.1007/s00428-004-1020-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-004-1020-6

Keywords

Navigation